UK Public Borrowing Surges to Highest Since Pandemic as Fuel Prices Weigh on Retail Sales April CPI Inflation Accelerates to 38 Annually Topping Expectations and Marking Highest Since May 2023 From Service to Skilled Trades The Untapped Pipeline Reshaping Americas Labor Market IRS Settlement Blocks Tax Audits on Trump and Family Implications for Financial Oversight FIS Gains Turnaround Momentum With Major Client Wins From Glencore and Commonwealth Bank US Payrolls Jump More Than Expected But Report Signals Underlying Economic Red Flags DCTH Q1 2026 Earnings SmallerthanExpected Loss Despite No Reported Revenue Bicara Therapeutics BCAX Q1 2026 Earnings ClinicalStage Biotech Reports WiderthanExpected Loss Shares Rise MNTK Earnings Overview 20260528 CRESY Q1 2026 Earnings Strong EPS Performance Amidst Challenging Macro Environment Biogen Q1 2026 Earnings Strong EPS Surprise of 2634 Boosts Investor Confidence LTC Properties Q1 2026 Earnings EPS Misses Estimates Stock Declines TKO Group Holdings TKO Rallies 586 Testing Key Resistance Zone PMTW Holds Steady Near Resistance PennyMac Mortgage Senior Notes Show Resilience Lake Shore Bancorp LSBK Slips Slightly as Shares Navigate Narrow Trading Range First Busey Preferred Stock BUSEP Holds Steady Near Resistance Modest Uptrend Underway Amalgamated Financial Corp AMAL Edges Lower as Sector Headwinds Persist Social Security Claiming Decision Weighing Full Retirement Age vs Delayed Benefits Sachem Capital Corp 600 Notes due 2027 SCCE Q4 2025 Earnings Massive EPS Surprise Highlights Resilient Operating Performance Rising Dragon Acquisition Corp RDAC Surges Nearly 10 as SPAC Shares Break Higher PEP Q1 2026 Earnings EPS Beat by 281 Amid Mixed Signals PHAR Q1 2026 Earnings EPS Misses Expectations by Wide Margin Stock Declines MSTR Q1 2026 Earnings EPS Falls Far Short of Estimates Stock Declines Redwood Trust Inc 900 Senior Notes Due 2029 RWTO Q1 2026 Earnings BottomLine Miss Underscores NearTerm Headwinds SWKHL Q3 2025 Earnings Strong EPS Beat of 70 Delivers 59 Cents Per Share KNF Q1 2026 Earnings Narrow EPS Beat Fails to Lift Shares Lyell Immunopharma Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues